今日VC

venture capital & Private Equity

Entries for 六月 4th, 2009

Finavera Renewables Secures $10 Million Funding Commitment

VANCOUVER, BRITISH COLUMBIAJune 3, 2009- Finavera Renewables Inc. (‘Finavera Renewables’ or the ‘Company’) (TSX VENTURE:FVR) is pleased to announce it has secured a $10,000,000 development loan from a European private family fund and current shareholder. The project development funding will be made available to the Company following the award of an Energy Purchase Agreement under [...]

LifeBond Raises $8 Million

LifeBond, an Israel-based developer of biosurgery devices, has raised $8 million in Series B funding. Pitango Venture Capital led the round, and was joined by return backers GlenRock Israel and The Zitelman Group.
The financing round of the biosurgery device company was led by Pitango Venture Capital and the investor Mr. Robert Taub. Also participating [...]

Grab Networks Raises $12 Million

Grab Networks, a Dulles, Va.-based provider of online video management software, has raised $12 million in venture debt and equity funding. Horizon Technology Finance led the debt portion, while the equity came from insiders like Softbank Capital, SCP Capital, Longworth Venture Partners and Court Square Partners. Grab was formed last September via the merger of [...]

Cloudera, the Commercial Hadoop Company, Closes Series B Funding

Led by Greylock Partners, Additional Funding to Accelerate Growth of Hadoop/MapReduce in Enterprise and Internet Markets
SAN FRANCISCO, Calif., June 2, 2009– Cloudera, the commercial Hadoop(TM) company, today announced that it has secured a Series B venture capital funding round led by Greylock Partners, bringing its total funding to date to more than $11 million. Aneel [...]

miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension

Extension Provides Total Series A Funding of $12 Million
BOULDER, Colo., June 2, 2009– miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA) based therapeutics for cardiovascular and muscle disease, today announced the achievement of several key milestones resulting in the approval of the second tranche of last year’s [...]